We are pleased to announce the new NATA Board of Directors for the 2025–2028 term, led by ChairSigismond Lasocki andPatrick Meybohm, Chair of the Scientific Committee.
The new Board brings together a diverse group of experts committed to advancing patient blood management, thrombosis, and haemostasis.